ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The Prognostic Value of Postoperative Radiotherapy for Thymoma and Thymic Carcinoma: A Propensity-Matched Study Based on SEER Database

Zhang, Chi; Wang, Qin; Hu, Liwen; Cong, Zhuangzhuang; Qiang, Yong; Xu, Fei; Zhang, Zheng; Luo, Chao; Qiu, Bingmei; Li, Xiaokun*; Shen, Yi*南方医科大学; 南京大学; 四川大学; y; xk
Cancers2022-10DOI: 10.3390/cancers14194938
1被引7阅读
引用收藏
分享

摘要

Simple Summary Although surgery has been recognized as the cornerstone of treatment for patients with resectable thymic epithelial tumors, the role of postoperative radiotherapy remains controversial. We performed this SEER-based propensity-matched analysis to investigate the prognostic value of postoperative radiotherapy in thymoma and thymic carcinoma. The results showed that postoperative radiotherapy improved both overall survival and cancer-specific survival in patients with Masaoka-Koga stage IIB-IV thymoma. This study is the first to demonstrate the prognostic value of postoperative radiotherapy in stage IIB thymic carcinoma. This large, up-to-date population-based longitudinal study may provide guidance on the use of postoperative radiotherapy for a thymoma or thymic carcinoma. (1) Objectives: The effect of postoperative radiotherapy (PORT) for thymoma and thymic carcinoma remains controversial. This study aimed to investigate the prognostic value of PORT for thymoma and thymic carcinoma in a population-based registry. (2) Methods: This retrospective study used the Surveillance, Epidemiology, and End Results (SEER) database to identify patients diagnosed with thymoma and thymic carcinoma between 2010 and 2019. Propensity score matching was performed to adjust statistical influences between the PORT and non-PORT groups. (3) Results: A total of 2558 patients with thymoma (n = 2138) or thymic carcinoma (n = 420) were included. In the multivariate analysis, PORT was an independent prognostic factor for OS (overall survival; p < 0.001) and CSS (cancer-specific survival; p = 0.001) in thymoma and an independent prognostic factor for OS in thymic carcinoma (p = 0.018). Subgroup analyses revealed that PORT was beneficial to OS and CSS in patients with Masaoka-Koga stage IIB-IV thymoma (OS: IIB, p < 0.001; III-IV, p = 0.005; CSS: IIB, p = 0.015; III-IV, p = 0.002) and stage IIB thymic carcinoma (OS: p = 0.012; CSS: p = 0.029). (4) Conclusion: This propensity-matched analysis identified the prognostic value of PORT in thymoma and thymic carcinoma based on the SEER database. For patients with stage IIB-IV thymoma and stage IIB thymic carcinoma, PORT was associated with improved OS and CSS. A more positive attitude towards the use of PORT for nonlocalized thymoma and thymic carcinoma may be appropriate.

学科与关键词

关键词
postoperative radiotherapyPORTthymomathymic carcinomaSEER programsurvival
相关
加载中…
  • Prognosis and surgical outcomes of the total thymectomy versus thymomectomy in non-myasthenic patients with early-stage thymoma: A systematic review and meta-analysis
    Xu, Congcong; Zhang, Qipeng; Li, Jiawei; Qiu, Hongbin; Zhu, Kanghao; Chen, Dong; Jin, Zixian; Zhang, Jian; Zhang, Bo; Witharana, Pasan; Chen, Baofu*; Xu, Enwu*; Shen, Jianfei*Asian Journal of Surgery, 2023, 46(9): 3455-3463.
  • Prognosis of radiotherapy in medullary thyroid carcinoma patients without distant metastasis
    Huang, Shaojun; Zhong, Jiana; Zhang, Zhen; Chen, Rongping; Li, Jitong; Sun, Jia*; Chen, Hong*Translational Cancer Research, 2021, 10(11): 4714-+.被引 1
  • Metabolomic and Transcriptomic Profiling Identified Significant Genes in Thymic Epithelial Tumor
    Tang, Enyu; Zhou, Yang; Liu, Siyang; Zhang, Zhiming; Zhang, Rixin; Huang, Dejing; Gao, Tong; Zhang, Tianze; Xu, Guangquan*Metabolites, 2022, 12(6): 567.被引 5
查看全部 →

发表信息

论文状态
公开发表
期刊
Cancers
发表日期
2022-10
卷期
第 14 卷, 第 19 期
页码
4938
DOI
10.3390/cancers14194938
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81702444]; Natural Science Foundation of Jiangsu Province [BK20181239]

作者

  • Z

    Zhang, Chi (第一作者)

    nanjing univ

  • W

    Wang, Qin

    nanjing univ

查看全部 11 位作者收起作者
  • H

    Hu, Liwen

    nanjing univ

  • C

    Cong, Zhuangzhuang

    nanjing univ

  • Q

    Qiang, Yong

    southeast univ

  • X

    Xu, Fei

    nanjing med univ

  • Z

    Zhang, Zheng

    nanjing med univ

  • L

    Luo, Chao

    southern med univ

  • Q

    Qiu, Bingmei

  • L

    Li, Xiaokun (通讯)

    sichuan univ

  • S

    Shen, Yi (通讯)

    southeast univ · nanjing med univ · nanjing univ · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417